XTL Biopharmaceuticals/$XTLB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About XTL Biopharmaceuticals
XTL Biopharmaceuticals Ltd is an intellectual property-based company focused on the development, management, and commercialization of intellectual property. The Company is engaged in biotechnology through its subsidiary Psyga Bio and in the biopharmaceutical industry with hCDR1, a novel compound working via a novel mechanism of action for the treatment of Systemic Lupus Erythematosus (SLE) and a potential treatment for Sjogren's syndrome (SS). It focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product candidates for the treatment of unmet clinical needs.
Ticker
$XTLB
Sector
Primary listing
Employees
5
Headquarters
Herzliya, Israel
Website
XTLB Metrics
BasicAdvanced
$6.4m
-
-$0.01
0.55
-
Price and volume
Market cap
$6.4m
Beta
0.55
52-week high
$4.87
52-week low
$2.01
Average daily volume
118k
Financial strength
Current ratio
0.395
Quick ratio
0.181
Interest coverage (TTM)
-209.29%
Profitability
EBITDA (TTM)
-1.266
Management effectiveness
Return on assets (TTM)
-21.01%
Return on equity (TTM)
-29.30%
Valuation
Price to book
-74.63
Price to tangible book (TTM)
-74.63
Price to free cash flow (TTM)
-2,467.192
Free cash flow yield (TTM)
-0.04%
Free cash flow per share (TTM)
-0.001
Growth
Earnings per share change (TTM)
413.38%
3-year earnings per share growth (CAGR)
46.83%
10-year earnings per share growth (CAGR)
-7.10%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.